| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,824 |
4,915 |
$295K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,046 |
774 |
$80K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,182 |
669 |
$60K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
603 |
536 |
$45K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
640 |
491 |
$44K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
945 |
802 |
$42K |
| 96127 |
|
1,042 |
853 |
$19K |
| 99000 |
|
778 |
581 |
$15K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
135 |
115 |
$12K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
112 |
100 |
$9K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
107 |
92 |
$8K |
| 92551 |
|
490 |
462 |
$7K |
| 90670 |
|
519 |
314 |
$6K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
250 |
174 |
$5K |
| 90686 |
|
379 |
324 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
81 |
54 |
$3K |
| 83655 |
|
202 |
131 |
$2K |
| 90697 |
|
135 |
83 |
$2K |
| 90648 |
|
248 |
179 |
$2K |
| 36416 |
|
459 |
353 |
$2K |
| 90680 |
|
113 |
67 |
$2K |
| 90723 |
|
138 |
105 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
43 |
38 |
$962.10 |
| 92587 |
|
69 |
39 |
$899.69 |
| 90633 |
|
67 |
40 |
$869.38 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
49 |
49 |
$769.30 |
| 90671 |
|
38 |
25 |
$687.62 |
| 85018 |
|
273 |
174 |
$633.36 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
46 |
43 |
$627.80 |
| 90381 |
|
24 |
13 |
$401.04 |
| 90661 |
|
19 |
14 |
$317.49 |
| 90696 |
|
25 |
15 |
$160.00 |
| 90710 |
|
22 |
14 |
$140.80 |
| 94760 |
|
93 |
85 |
$35.20 |
| 99051 |
|
176 |
165 |
$0.00 |
| 1003F |
|
1,873 |
1,590 |
$0.00 |
| 99177 |
|
272 |
239 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,121 |
1,508 |
$0.00 |
| 90461 |
|
1,123 |
790 |
$0.00 |
| 99072 |
|
701 |
600 |
$0.00 |
| 1220F |
|
159 |
125 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16 |
16 |
$0.00 |
| 1036F |
|
360 |
309 |
$0.00 |